Medicated sex in Britain: evidence from the third National Survey of Sexual Attitudes and Lifestyles
- Kirstin R Mitchell1,
- Philip Prah2,
- Catherine H Mercer2,
- Jessica Datta1,
- Clare Tanton2,
- Wendy Macdowall1,
- Andrew J Copas2,
- Soazig Clifton2,
- Pam Sonnenberg2,
- Nigel Field2,
- Anne M Johnson2,
- Kaye Wellings1
- 1Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK
- 2Research Department of Infection and Population Health, University College London, London, UK
- Correspondence to Dr Kirstin Mitchell, Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK;
- Received 16 March 2015
- Revised 20 May 2015
- Accepted 25 May 2015
- Published Online First 19 June 2015
Objectives To describe the prevalence of medication use to assist sexual performance in Britain and to identify associated factors.
Methods Cross-sectional probability sample, undertaken in 2010–2012, of 15 162 people aged 16–74 years, resident in Britain, of whom, 5617 men and 8095 women reported sexual experience (ever) and 4817 men were sexually-active (reported sex in the last year).
Results Ever use of medication to assist sexual performance (medicated sex) was more commonly reported by men than women (12.9% (95% CI 11.9% to 13.9%) vs 1.9% (95% CI 1.7% to 2.3%)) and associated with older age in men and younger age in women. It was associated with reporting smoking, and use of alcohol and recreational drugs, as well as unsafe sex (≥2 partners and no condom use in the last year) in both men and women. Among men, the proportion reporting medicated sex in the last year was higher among those reporting erectile difficulties (ED) than those not doing so (28.4% (95% CI 24.4% to 32.8%) vs 4.1% (95% CI 3.4% to 4.9%)). In all men, medicated sex was associated with more frequent sexual activity, meeting a partner on the internet, unsafe sex and recent sexually transmitted infections diagnosis; associations that persisted after adjusting for same-sex behaviour and ED. However, there were significant interactions with reporting ED, indicating that among men with ED, medicated sex is not associated with same-sex behaviour and ever use of recreational drugs.
Conclusions A substantial minority of people in Britain report medicated sex, and the association between medicated sex and risky sexual behaviour is not confined to high-risk groups.
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/